Cancer Epidemiology, Biomarkers & Prevention, 21, 1362-1370 Cancer Epidemiology, Biomarkers and Prevention, 21(8), 1362-1370 Cancer Epidemiology Biomarkers and Prevention, 21(8), 1362-1370. American Association for Cancer Research Inc. Ding, Y C, McGuffog, L, Healey, S, Friedman, E, Laitman, Y, Paluch-Shimon, S, Kaufman, B, Liljegren, A, Lindblom, A, Olsson, H, Kristoffersson, U, Stenmark-Askmalm, M, Melin, B, Domchek, S M, Nathanson, K L, Rebbeck, T R, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Gronwald, J, Huzarski, T, Cybulski, C, Byrski, T, Osorio, A, Cajal, T R, Stavropoulou, A V, Benítez, J, Hamann, U, Rookus, M, Aalfs, C M, de Lange, J L, Meijers-Heijboer, H E J, Oosterwijk, J C, van Asperen, C J, Gómez García, E B, Hoogerbrugge, N, Jager, A, van der Luijt, R B, Easton, D F, Peock, S, Frost, D, Ellis, S D, Platte, R, Fineberg, E, Evans, D G, Lalloo, F, Izatt, L, Hansen, T V O, Jensen, U B, Skytte, A-B S & SWE-BRCA 2012, ' A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers ', Cancer Epidemiology, Biomarkers & Prevention, vol. 21, no. 8, pp. 1362-70 . https://doi.org/10.1158/1055-9965.EPI-12-0229 Ding, Y C, McGuffog, L, Healey, S, Friedman, E, Laitman, Y, Shani, P S, Kaufman, B, Liljegren, A, Lindblom, A, Olsson, H, Kristoffersson, U, Stenmark-Askmalm, M, Melin, B, Domchek, S M, Nathanson, K L, Rebbeck, T R, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Gronwald, J, Huzarski, T, Cybulski, C, Byrski, T, Osorio, A, Cajal, T R, Stavropoulou, A V, Benitez, J, Hamann, U, Rookus, M, Aalfs, C M, de Lange, J L, Meijers-Heijboer, E J, Oosterwijk, J C, van Asperen, C J, Garcia, E B G, Hoogerbrugge, N, Jager, A, van der Luijt, R B, Easton, D F, Peock, S, Frost, D, Ellis, S D, Platte, R, Fineberg, E, Evans, D G, Lalloo, F, Izatt, L, Eeles, R, Adlard, J, Davidson, R, Eccles, D, Cole, T, Cook, J, Brewer, C, Tischkowitz, M, Godwin, A K, Pathak, H, Stoppa-Lyonnet, D, Sinilnikova, O M, Mazoyer, S, Barjhoux, L, Leone, M, Gauthier-Villars, M, Caux-Moncoutier, V, de Pauw, A, Hardouin, A, Berthet, P, Dreyfus, H, Ferrer, S F, Collonge-Rame, M A, Sokolowska, J, Buys, S, Daly, M, Miron, A, Terry, M B, Chung, W, John, E M, Southey, M, Goldgar, D, Singer, C F, Tea, M K M, Gschwantler-Kaulich, D, Fink-Retter, A, Hansen, T V O, Ejlertsen, B, Johannsson, O T, Offit, K, Sarrel, K, Gaudet, M M, Vijai, J, Robson, M, Piedmonte, M R, Andrews, L, Cohn, D, Demars, L R, DiSilvestro, P, Rodriguez, G & Toland, A E 2012, ' A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers ', Cancer Epidemiology Biomarkers and Prevention, vol. 21, no. 8, pp. 1362-1370 . https://doi.org/10.1158/1055-9965.EPI-12-0229 Cancer Epidemiology, Biomarkers & Prevention, 21, 8, pp. 1362-1370 Cancer Epidemiology Biomarkers & Prevention, 21(8), 1362-1370. American Association for Cancer Research Inc. Cancer epidemiology, biomarkers & prevention, 21(8), 1362-1370. American Association for Cancer Research Inc. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(8), 1362-1370. AMER ASSOC CANCER RESEARCH Ding, Y C, McGuffog, L, Healey, S, Friedman, E, Laitman, Y, Paluch-Shimon, S, Kaufman, B, Liljegren, A, Lindblom, A, Olsson, H, Kristoffersson, U, Stenmark-Askmalm, M, Melin, B, Domchek, S M, Nathanson, K L, Rebbeck, T R, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Gronwald, J, Huzarski, T, Cybulski, C, Byrski, T, Osorio, A, Cajal, T R, Stavropoulou, A V, Benítez, J, Hamann, U, Rookus, M, Aalfs, C M, de Lange, J L, Meijers-Heijboer, H E J, Oosterwijk, J C, van Asperen, C J, Gómez García, E B, Hoogerbrugge, N, Jager, A, van der Luijt, R B, Easton, D F, Peock, S, Frost, D, Ellis, S D, Platte, R, Fineberg, E, Evans, D G, Lalloo, F, Gerdes, A-M, Thomassen, M, Skytte, A-B & SWE-BRCA 2012, ' A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers ', Cancer Epidemiology, Biomarkers & Prevention, vol. 21, no. 8, pp. 1362-70 . https://doi.org/10.1158/1055-9965.EPI-12-0229
Cancer Epidemiology Biomarkers & Prevention; Vol 21 Cancer Epidemiology Biomarkers & Prevention, 21(1), 134-147. American Association for Cancer Research Inc. Cancer Epidemiology, Biomarkers & Prevention, 21, 1, pp. 134-47 Cancer Epidemiology, Biomarkers and Prevention, 21(1), 134-147 Cancer Epidemiology, Biomarkers & Prevention, 21, 134-47 Mavaddat, N, Barrowdale, D, Andrulis, I L, Domchek, S M, Eccles, D, Nevanlinna, H, Ramus, S J, Spurdle, A, Robson, M, Sherman, M, Mulligan, A M, Couch, F J, Engel, C, McGuffog, L, Healey, S, Sinilnikova, O M, Southey, M C, Terry, M B, Goldgar, D, O'Malley, F, John, E M, Janavicius, R, Tihomirova, L, Hansen, T V O, Nielsen, F C, Osorio, A, Stavropoulou, A, Benítez, J, Manoukian, S, Peissel, B, Barile, M, Volorio, S, Pasini, B, Dolcetti, R, Putignano, A L, Ottini, L, Radice, P, Hamann, U, Rashid, M U, Hogervorst, F B, Kriege, M, van der Luijt, R B, Peock, S, Frost, D, Evans, D G, Brewer, C, Walker, L, Thomassen, M, Gerdes, A-M, Kruse, T & for HEBON 2011, ' Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) ', Cancer Epidemiology, Biomarkers & Prevention, vol. 21, no. 1, pp. 134-47 . https://doi.org/10.1158/1055-9965.EPI-11-0775